Chikungunya Fever Spreading: Travel Warnings Issued for Island Destinations
Travelers planning trips to idyllic island destinations are being warned of a growing outbreak of chikungunya fever (CHIKV). Cases are being reported in popular tourist spots like the Seychelles, Mauritius, and Madagascar, prompting health organizations to issue travel advisories.
Mayotte at the Epicenter of the Outbreak
The most concerning situation is currently on the island of Mayotte in the Indian Ocean, according to Slovakia’s Public Health Institute. As of January 1, 2026, over 270 locally acquired cases have been confirmed. In the last two weeks of February, an average of 65 cases were reported weekly.
Widespread Transmission Across the Indian Ocean
In 2026, CHIKV cases have likewise been reported in the Seychelles. Circulation of the virus has been detected on Réunion Island, Mauritius, Madagascar, and the Comoros Islands. This indicates a broader regional spread of the disease.
Understanding Chikungunya Symptoms and Risks
Chikungunya symptoms typically include fever and joint pain, along with headaches and muscle aches. The illness can lead to long-term health problems, particularly in older adults and individuals with pre-existing medical conditions. The virus can also be transmitted from a pregnant mother to her unborn child, posing a potentially fatal risk to newborns.
Continued Epidemic Activity Expected
The European Centre for Disease Prevention and Control (ECDC) explains that Mayotte is currently in its rainy season, creating ideal breeding conditions for Aedes mosquitoes – the vectors responsible for transmitting CHIKV. The rainy season is expected to end in April.
The ECDC anticipates the epidemic will continue in the coming months, emphasizing the importance of communicating risks to travelers and travel clinics. Enhanced preventative measures are crucial.
Preventative Measures for Travelers
Preventative measures include using mosquito repellent, sleeping under mosquito nets or in closed, air-conditioned rooms, and wearing clothing that covers as much of the body as possible. Vaccination should be considered based on individual country recommendations.
Currently, the likelihood of CHIKV spreading in mainland Europe due to infected travelers is considered low. Winter environmental conditions are not favorable for Aedes mosquito activity and viral replication.
Past Outbreaks and Regional Immunity
Mayotte experienced an outbreak in 2025, with a total of 1,270 confirmed CHIKV cases, peaking in the 21st week of the year with 232 cases. Reported case numbers for 2025 are likely underestimated due to limited healthcare access in some areas of Mayotte following a devastating cyclone.
A significant outbreak occurred on Réunion Island in 2025, resulting in approximately 66% population immunity. Locally acquired cases were also reported in other areas of the Indian Ocean.
Did you know?
Chikungunya is not typically fatal, but the joint pain can be debilitating and persist for months or even years in some individuals.
Frequently Asked Questions
Q: What is chikungunya?
A: Chikungunya is a viral disease transmitted to humans through mosquito bites.
Q: How can I protect myself from chikungunya?
A: Use mosquito repellent, wear protective clothing, and sleep in screened or air-conditioned rooms.
Q: Is there a vaccine for chikungunya?
A: Vaccination may be considered based on recommendations in your country of origin.
Q: Is chikungunya a serious illness?
A: While rarely fatal, chikungunya can cause severe joint pain and long-term health problems.
Q: What should I do if I feel I have chikungunya?
A: Seek medical attention and inform your doctor about your recent travel history.
Pro Tip: Check the CDC and ECDC websites for the latest travel advisories and health recommendations before your trip.
Stay informed about the evolving situation and take necessary precautions to protect your health while traveling. Explore the ECDC website for monthly updates on chikungunya cases.
